Mark Daris

1.1k total citations
18 papers, 444 citations indexed

About

Mark Daris is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mark Daris has authored 18 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Mark Daris's work include CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Mark Daris is often cited by papers focused on CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Mark Daris collaborates with scholars based in United States. Mark Daris's co-authors include Jackie Sheng, Brad Bolon, Sean Morony, Christopher Carter, Paul J. Kostenuik, Alexander Kamb, Agnes E. Hamburger, Zhaopo Geng, Talar Tokatlian and Grace E. Asuelime and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Bone.

In The Last Decade

Mark Daris

18 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Daris United States 10 279 243 127 125 47 18 444
Katrin Birkholz Germany 9 225 0.8× 152 0.6× 86 0.7× 185 1.5× 20 0.4× 19 362
Iñigo Tirapu Spain 17 457 1.6× 213 0.9× 127 1.0× 559 4.5× 49 1.0× 32 888
Emily Stein United States 7 90 0.3× 107 0.4× 19 0.1× 157 1.3× 16 0.3× 10 340
Daosheng Huang China 8 289 1.0× 187 0.8× 95 0.7× 146 1.2× 2 0.0× 12 464
Saral N. Amarnani United States 8 331 1.2× 201 0.8× 60 0.5× 477 3.8× 4 0.1× 8 600
Kathy Call United States 6 55 0.2× 364 1.5× 107 0.8× 49 0.4× 18 0.4× 7 458
Mina O. Seedhom United States 8 209 0.7× 148 0.6× 49 0.4× 271 2.2× 2 0.0× 14 503
Berith Nilsson Sweden 9 282 1.0× 203 0.8× 199 1.6× 223 1.8× 12 541
Claire Battin Austria 12 243 0.9× 102 0.4× 13 0.1× 264 2.1× 4 0.1× 23 441
Lydia Haile United States 12 230 0.8× 183 0.8× 37 0.3× 625 5.0× 5 0.1× 13 769

Countries citing papers authored by Mark Daris

Since Specialization
Citations

This map shows the geographic impact of Mark Daris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Daris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Daris more than expected).

Fields of papers citing papers by Mark Daris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Daris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Daris. The network helps show where Mark Daris may publish in the future.

Co-authorship network of co-authors of Mark Daris

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Daris. A scholar is included among the top collaborators of Mark Daris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Daris. Mark Daris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Jingli A., Sanam Shafaattalab, Jianying Liang, et al.. (2025). Onboard, tethered IL-12 boosts potency of the Tmod NOT gate and preserves selectivity. Journal for ImmunoTherapy of Cancer. 13(5). e010976–e010976. 1 indexed citations
2.
DiAndreth, Breanna, Aaron Winters, Claudia A. Jette, et al.. (2025). Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy. Frontiers in Immunology. 16. 1493329–1493329. 3 indexed citations
3.
Shafaattalab, Sanam, Erica R. Vander Mause, Aaron Winters, et al.. (2024). Geometric parameters that affect the behavior of logic-gated CAR T cells. Frontiers in Immunology. 15. 1304765–1304765. 5 indexed citations
4.
Tokatlian, Talar, Grace E. Asuelime, Martin S. Naradikian, et al.. (2022). Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity. Cancer Research Communications. 2(1). 58–65. 8 indexed citations
5.
Tokatlian, Talar, Grace E. Asuelime, Breanna DiAndreth, et al.. (2022). Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells. Journal for ImmunoTherapy of Cancer. 10(1). e003826–e003826. 49 indexed citations
6.
Wang, Xueyin, Mark L. Sandberg, Michele McElvain, et al.. (2021). Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers. Journal of Immunotherapy. 44(8). 292–306. 19 indexed citations
7.
Oh, Julyun, et al.. (2021). Design of TCR Structural Variants That Retain or Invert the Normal Activation Signal. ImmunoHorizons. 5(5). 349–359. 3 indexed citations
8.
Han, Xu, Agnes E. Hamburger, Xueyin Wang, et al.. (2020). Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen. Molecular Immunology. 126. 56–64. 14 indexed citations
9.
Zhao, Huiren, Ki Jeong Lee, Mark Daris, et al.. (2020). Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach. Molecular Therapy — Methods & Clinical Development. 18. 312–320. 73 indexed citations
10.
11.
Sckisel, Gail D., Anupama Sahoo, Almin Lalani, et al.. (2020). Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. Frontiers in Immunology. 11. 832–832. 55 indexed citations
12.
Wang, Xueyin, Xu Han, Alexander Kamb, et al.. (2020). 125 Reexamination of MAGE-A3 as a T-cell Therapeutic Target. Regular and Young Investigator Award Abstracts. A76.1–A76. 1 indexed citations
13.
Hamburger, Agnes E., Breanna DiAndreth, Jiajia Cui, et al.. (2020). Engineered T cells directed at tumors with defined allelic loss. Molecular Immunology. 128. 298–310. 37 indexed citations
14.
DiAndreth, Breanna, Jiajia Cui, Mark Daris, et al.. (2020). 115 Engineered T cells directed at tumors with defined allelic loss. SHILAP Revista de lepidopterología. A71.1–A71. 1 indexed citations
15.
Spahr, Chris, Mark Daris, Kevin C. Graham, et al.. (2018). Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells. mAbs. 10(8). 1291–1300. 10 indexed citations
16.
Kostenuik, Paul J., Brad Bolon, Sean Morony, et al.. (2004). Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone. 34(4). 656–664. 66 indexed citations
17.
Bolon, Brad, Christopher Carter, Mark Daris, et al.. (2001). Adenoviral Delivery of Osteoprotegerin Ameliorates Bone Resorption in a Mouse Ovariectomy Model of Osteoporosis. Molecular Therapy. 3(2). 197–205. 85 indexed citations
18.
Bolon, Brad, Mark Daris, Sean Morony, et al.. (2001). Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease. Arthritis Research. 3(Suppl 1). P5–P5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Birkholz Breakdown of academic impact, for papers by Iñigo Tirapu Breakdown of academic impact, for papers by Emily Stein Breakdown of academic impact, for papers by Daosheng Huang Breakdown of academic impact, for papers by Saral N. Amarnani Breakdown of academic impact, for papers by Kathy Call Breakdown of academic impact, for papers by Mina O. Seedhom Breakdown of academic impact, for papers by Berith Nilsson Breakdown of academic impact, for papers by Claire Battin Breakdown of academic impact, for papers by Lydia Haile
Rankless by CCL
2026